Skip to main content
Log in

Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab

  • Case Report
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

We encountered a case of reactivation of hepatitis B virus after administration of infliximab for Crohn’s disease. The use of infliximab was considered because the patient displayed abdominal symptoms and perianal lesions. Transaminases were normal, and hepatitis B virus (HBV) DNA was undetectable before treatment, so no antiviral treatment was used, and infliximab and low-dose 6-mercaptopurine were administered. This treatment was effective, but liver dysfunction and reactivation of HBV were observed after the fourth injection of infliximab. This is the first report of Crohn’s disease for which infliximab use was continued even after reactivation of HBV was observed. However, liver dysfunction was not improved by lamivudine. Antiviral treatment should be considered before administration of infliximab for patients with HBV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Candy S, Wright JP, Gerber M, Adams G, Gerig M, Goodman R. A double blind controlled study of azathioprine in the treatment and maintenance of remission in Crohn’s disease. Gut 1995;37:674–678.

    Article  PubMed  CAS  Google Scholar 

  2. Ewe K, Press A, Singe C, Stufler M, Ueberschaer B, Hommel G, et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn’s disease. Gastroenterology 1993;105:367–372.

    PubMed  CAS  Google Scholar 

  3. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn’s disease with 6-mercaputopurine: a long-term, randomized, double blind study. N Engl J Med 1980;302:981–987.

    PubMed  CAS  Google Scholar 

  4. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaputopurine with Crohn’s disease. A meta-analysis. Ann Intern Med 1995;122:132–142.

    Google Scholar 

  5. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med 1997;337:1029–1035.

    Article  PubMed  CAS  Google Scholar 

  6. Present DH, Rutgeerts P, Targan SR, Hanauer SB, Mayer L, van Deventer SJ, et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 1999;340:1398–1405.

    Article  PubMed  CAS  Google Scholar 

  7. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 2004;350:876–885.

    Article  PubMed  CAS  Google Scholar 

  8. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462–2476.

    Article  PubMed  CAS  Google Scholar 

  9. Michel M, Duvoux C, Hezode C, Cherqui D. Fulminant hepatitis after infliximab in a patients with hepatitis B virus treated for an adult onset Still’s disease. J Rheumatol 2003;30:1624–1625.

    PubMed  Google Scholar 

  10. Ostuni P, Botsios C, Punzi L, Sfriso P, Todesco S. Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 2003;62:686–687.

    Article  PubMed  CAS  Google Scholar 

  11. Ueno Y, Tanaka S, Shimamoto M, Miyanaka Y, Hiyama T, Ito M, et al. Infliximab therapy for Crohn’s disease in a patient with chronic hepatitis B. Dig Dis Sci 2005;50:163–166.

    Article  PubMed  Google Scholar 

  12. Wendling D, Auge B, Betting D, Lohse A, Huede GL, Bresson-Hadni S, et al. Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy. Ann Rheum Dis 2005;64:788–789.

    Article  PubMed  CAS  Google Scholar 

  13. Millonig G, Kern M, Ludwiczec O, Vogel W. Subfulminant hepatitis B after infliximab in Crohn’s disease: need for HBV-screening. World J Gastroenterol 2006;12:974–976.

    PubMed  Google Scholar 

  14. Madonia S, Orlando A, Scimeca D, Olivio M, Rossi F, Cottone M. Occult hepatitis B and infliximab-induced HBV reactivation. Inflamm Bowel Dis 2007;4:508–509.

    Article  Google Scholar 

  15. Esteve M, Saro C, Gonzalez-Huix F, Suarex F, Forne M, Viver JM. Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease. Gut 2004;53:1363–1365.

    Article  PubMed  CAS  Google Scholar 

  16. del Valle Garcia-Sanchez M, Iglesias-Flores EM, de Dios-Vega JF, Gomes-Camacho F. Poyato-Ganzalez, Sancho-Zapatero R. Inflamm Bowel Dis 2004;10:701–702.

    Article  Google Scholar 

  17. Oniankitan O, Duvoux C, Challine D, Mallat A, Chevalier X, Pawlotsky J, et al. Infliximab therapy for rheumatic disease in patients with chronic hepatitis B or C. J Reumatol 2004;31:107–109.

    CAS  Google Scholar 

  18. Van Assche GA, Paintaud G, D’Haens G. Continuation of immunomodulators is not required to maintain adequate infliximab efficacy in patients with Crohn’s disease but may improve pharmacokinetics. Gastroenterology 2006;130Suppl 2:A923.

    Google Scholar 

  19. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507–539.

    Article  PubMed  CAS  Google Scholar 

  20. Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology 2006;43:209–220.

    Article  PubMed  CAS  Google Scholar 

  21. Nathan DM, Angus PW, Gibson PR. Hepatitis B and C virus infections and anti-tumor necrosis factor-a therapy: guidelines for clinical approach. J Gastroenterol Hepatol 2006;21:1366–1371.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ojiro, K., Naganuma, M., Ebinuma, H. et al. Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab. J Gastroenterol 43, 397–401 (2008). https://doi.org/10.1007/s00535-008-2165-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-008-2165-x

Key words

Navigation